Clinical trial
Immune Responses to Revaccination After Potentially Insufficient Priming With the Japanese Encephalitis Vaccine IXIARO Batch JEV09L37
NCT01559831 is registered in ClinicalTrials.gov with Valneva Austria GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Responses to Revaccination After Potentially Insufficient Priming With the Japanese Encephalitis Vaccine IXIARO Batch JEV09L37
- Lead sponsor
- Valneva Austria GmbH
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- June 30, 2012
- Completion date
- March 31, 2013
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
japanese encephalitis